Generated by Meeveem AI
"A UK pharma company developing niche generic medicines for complex medical challenges."
Aspire Pharma develops and supplies niche generic medicines across ten therapy areas including oncology, cardiology, dermatology and respiratory. Founded in 2009, the company enhances existing medicines by improving formulations, presentations and dosing to increase patient access and solve complex healthcare challenges for the NHS and EU health systems. The business operates with a clear commitment to sustainability, innovation and partnership, licensing and developing products that make measurable value for patients and healthcare professionals. With over 400 products in its portfolio and a growing international reach, Aspire combines agility with deep knowledge of UK and European healthcare to bring better medicines to market.
96
Team Members
2009
Founded
Pharma
Sector
Hybrid
Work Environment
A healthcare system where every patient has access to the medicines they need, delivered sustainably and with proven value for health systems worldwide.
Our mission is to make a difference in the lives of patients through the development and supply of innovative products and medicines throughout the world.